Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lenz

Showing results (281-290 of 367) with videos related to

Pageof 37
Sort By:
British Journal of Cancer|September 12, 2013
Higher capecitabine AUC in elderly patients with advanced colorectal cancer (SWOGS0030)S G Louie, B Ely, H-J Lenz, et al.
The Pharmacogenomics Journal|April 10, 2013
The cyclin D1 (CCND1) rs9344 G>A polymorphism predicts clinical outcome in colon cancer patients treated with adjuvant 5-FU-based chemotherapyG Absenger, L Benhaim, J Szkandera, et al.
Clinical Transplantation|November 15, 1997
Current issues in living donor nephrectomyK W Jones, T G Peters, R K Charlton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 2, 1998
p53 and thymidylate synthase expression in untreated stage II colon cancer: associations with recurrence, survival, and siteH J Lenz, K D Danenberg, C G Leichman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 14, 2008
Polymorphisms in VEGF and IL-8 predict tumor recurrence in stage III colon cancerG Lurje, W Zhang, A M Schultheis, et al.
Cancer Chemotherapy and Pharmacology|October 18, 2014
Phase II study of selumetinib (AZD6244, ARRY-142886) plus irinotecan as second-line therapy in patients with K-RAS mutated colorectal cancerH S Hochster, N Uboha, W Messersmith, et al.
The Pharmacogenomics Journal|November 30, 2016
Germline polymorphisms as biomarkers of tumor response in colorectal cancer patients treated with anti-EGFR monoclonal antibodies: a systematic review and meta-analysisE K Morgen, H-J Lenz, D J Jonker, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 29, 2000
Immunologic responses of HIV-1-infected study subjects to immunization with a mixture of peptide protein derivative-V3 loop peptide conjugatesA Rubinstein, Y Mizrachi, M Pettoello-Mantovani, et al.
Thrombosis and Haemostasis|August 25, 2017
Apixaban and dalteparin in active malignancy associated venous thromboembolism. The ADAM VTE TrialRobert McBane Ii, Charles L Loprinzi, Aneel Ashrani, et al.
The Science of the Total Environment|June 26, 2021
Do foodborne polyethylene microparticles affect the health of rainbow trout (Oncorhynchus mykiss)?N Hodkovicova, A Hollerova, H Caloudova, et al.
Pageof 37

Showing results (281-290 of 367) with videos related to

Sort By:
Pageof 37
British Journal of Cancer|September 12, 2013
Higher capecitabine AUC in elderly patients with advanced colorectal cancer (SWOGS0030)S G Louie, B Ely, H-J Lenz, et al.
The Pharmacogenomics Journal|April 10, 2013
The cyclin D1 (CCND1) rs9344 G>A polymorphism predicts clinical outcome in colon cancer patients treated with adjuvant 5-FU-based chemotherapyG Absenger, L Benhaim, J Szkandera, et al.
Clinical Transplantation|November 15, 1997
Current issues in living donor nephrectomyK W Jones, T G Peters, R K Charlton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 2, 1998
p53 and thymidylate synthase expression in untreated stage II colon cancer: associations with recurrence, survival, and siteH J Lenz, K D Danenberg, C G Leichman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 14, 2008
Polymorphisms in VEGF and IL-8 predict tumor recurrence in stage III colon cancerG Lurje, W Zhang, A M Schultheis, et al.
Cancer Chemotherapy and Pharmacology|October 18, 2014
Phase II study of selumetinib (AZD6244, ARRY-142886) plus irinotecan as second-line therapy in patients with K-RAS mutated colorectal cancerH S Hochster, N Uboha, W Messersmith, et al.
The Pharmacogenomics Journal|November 30, 2016
Germline polymorphisms as biomarkers of tumor response in colorectal cancer patients treated with anti-EGFR monoclonal antibodies: a systematic review and meta-analysisE K Morgen, H-J Lenz, D J Jonker, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 29, 2000
Immunologic responses of HIV-1-infected study subjects to immunization with a mixture of peptide protein derivative-V3 loop peptide conjugatesA Rubinstein, Y Mizrachi, M Pettoello-Mantovani, et al.
Thrombosis and Haemostasis|August 25, 2017
Apixaban and dalteparin in active malignancy associated venous thromboembolism. The ADAM VTE TrialRobert McBane Ii, Charles L Loprinzi, Aneel Ashrani, et al.
The Science of the Total Environment|June 26, 2021
Do foodborne polyethylene microparticles affect the health of rainbow trout (Oncorhynchus mykiss)?N Hodkovicova, A Hollerova, H Caloudova, et al.
Pageof 37